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Objectives: In clinical stage IA lung adenocarcinoma, the clinical
features of a truly node-negative population were prospectively
investigated by means of a prospective investigational study.
Methods: The clinical data and radiographic features of high-
resolution computed tomography (HR-CT) were registered before
operation in 169 clinical stage IA lung cancer patients who were
scheduled to undergo a standard lobectomy and systemic mediasti-
nal node dissection. The nodal metastasis was pathologically defined
and the clinical factors associated with the presence of the nodal
metastasis were evaluated.
Results: In 114 assessable cases with adenocarcinomas, 15 (13.1%)
were node-positive. The serum carcinoembryonic antigen (CEA),
retraction sign, and intratumoral air-bronchogram on HR-CT were
suggested to be predictive factors for lymph node metastasis, with
hazard ratios of 12.44 (p  0.0003), 6.53 (p  0.0533), and 0.17
(p  0.0073), respectively. In combination with the radiologic
features and serum CEA, cases with elevated serum CEA or pres-
ence of retraction sign included 15.6% of node metastasis-positive,
whereas all cases with normal CEA and absence of retraction sign
showed no nodal metastasis. Cases with elevated serum CEA or
absence of intratumoral air-bronchogram included 24.5% of node
metastasis, whereas cases with normal CEA and presence of air-
bronchogram showed 4.6% of node metastasis. The tumor size and
the proportion of ground-glass attenuation were not associated with
the incidence of nodal metastasis.
Conclusions: The serum CEA and HR-CT features thus allowed us
to identify node-negative lung adenocarcinomas measuring 3 cm or
less in size.
Key Words: Non-small cell lung cancer, Limited resection, Tumor,
node, metastasis (TNM) stage, Lymph node metastasis, High-resolution
computed tomography.
(J Thorac Oncol. 2006;1: 825–831)
Because of recent advances in such diagnostic tools ascomputed tomography (CT), the chance of detecting and
thus performing surgery on peripheral small-sized lung can-
cers has increased.1 A limited resection for peripheral type
non-small cell lung cancer (NSCLC) is well indicated in
patients with a compromised cardiopulmonary reserve, al-
though its clinical outcome is relatively unfavorable in com-
parison with a standard lobectomy.2,3 The application of an
intentional limited resection for every peripheral small-sized
NSCLC remains controversial. A prospective, randomized
trial conducted by the Lung Cancer Study Group showed a
significantly higher frequency of local relapse in the limited
resection group than in the standard lobectomy group.4 The
selection criteria for patients with indications to undergo a
limited resection therefore have to be established. The largest
issue to be solved is the preoperative evaluation criteria for
nodal metastasis. In the clinical staging of NSCLC, an ex-
amination of the nodal factors by CT scanning is still unsat-
isfactory, and more than 20% of clinically defined stage IA
cases proved to have nodal metastasis by pathologic exami-
nation of surgical specimens.5,6 Until now, several authors
have reported a positive relationship between tumor size and
regional lymph node metastasis. Asamura et al.5 reported that
16.3% of cases of NSCLC with a primary tumor measuring 3
cm or less in diameter showed hilar or mediastinal node
metastasis, whereas even in cases with tumors measuring 2
cm or less in size, 21% of adenocarcinomas showed node
metastasis and 6% of squamous cell carcinomas showed
nodal metastasis. Ohta et al.7 demonstrated tumor size to be
significantly associated with nodal metastasis in squamous
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cell carcinoma but not in adenocarcinoma in clinical stage I
NSCLC. Therefore, the tumor size may not be a definitive
condition for a lesser resection.
To establish the criteria for indicating an intentional
limited resection without any nodal dissection of peripheral
small-sized NSCLC, the preoperative selection of “true stage
IA” (node-negative) is required. In this study, we prospec-
tively investigated the features of node-negative adenocarci-
noma of the lung.
PATIENTS AND METHODS
Registration of Patients
The protocol of this study was permitted by the insti-
tutional review boards of all cooperative institutes. The pa-
tients were enrolled between September 1, 2003, and August
31, 2005. High-resolution (HR) CT was used for clinical
intrathoracic staging and for characterization of the radio-
graphic features. Positron emission tomography was not used
for evaluation for preoperative staging.
The inclusion criteria of this study were as follows: (1)
pathologically or cytologically proven lung cancer, or strong
suspicion of lung cancer by radiographic examinations; (2)
with a larger diameter of a primary tumor of less than 3 cm;
(3) more than 3 cm between the proximal margin of the tumor
and hilar vessels; (4) no enlarged regional lymph nodes; (5)
the ability to tolerate a standard lobectomy; (6) no prior
anticancer treatment; and (7) written informed consent. The
exclusion criteria were as follows: (1) the presence of meta-
chronous or synchronous multiple lung cancer or thoracic
malignancies; (2) a history of thoracic radiation; and (3) the
presence of uncontrollable complications.
Study Design
The study was performed in a multi-institutional set-
ting. The clinical data and radiographic features of HR-CT
described below were registered at the entry of this study
before operation. Next, the pathologic data of a surgical
specimen of a standard operation (lobectomy and systemic
mediastinal node dissection) were collected, and the relation-
ship between the presence or absence of nodal metastasis and
the clinical and radiographic factors was investigated. A
systemic node dissection was performed uniformly among all
institutions, and the policy was as follows: when a primary
tumor was located at the right upper or middle lobe, lymph
nodes at stations 1, 2, 3, 4, 7, 10, 11, and 12 and intralobar
nodes were dissected. When a primary tumor was located at
the right lower lobe, lymph nodes at stations 1, 2, 3, 4, 7, 8,
9, 10, 11, and 12 were dissected in addition to intrapulmonary
nodes. When a primary tumor was located at the left upper
lobe, lymph nodes at stations 4, 5, 6, 7, 10, 11, and 12 were
dissected. When a primary tumor was located at the left lower
lobe, lymph nodes at stations 4, 5, 6, 7, 8, 9, 10, 11, and 12
were dissected.
Preoperative Parameters
Clinical data and radiographic features of HR-CT were
registered before the operation. The clinical data collected
included the (1) smoking status, (2) serum level of carcino-
embryonic antigen (CEA) detected by enzyme-linked immu-
nosorbent assay (the cutoff value was decided according to
each institutional laboratory), and (3) the histologic type
based on the criteria of the World Health Organization.8 The
HR-CT features of the primary lesion were (1) the lobe
location; (2) a retraction sign such as pleural retraction or
vascular convergence; (3) the intratumoral air-bronchogram;
(4) the intratumoral cavity; (5) notching; (6) an obstructive
sign such as peripheral atelectasis, hyperinflation, or pneu-
monia; and (7) the proportion of ground-glass attenuation
(GGA) (GGA ratio, calculated as [the largest diameter –
diameter of non-GGA portion]/the largest diameter).
The definition of GGA was determined to be a hazy
increase in lung attenuation without obscuration of the un-
derlying vascular marking based on the HR-CT scan findings,
mainly, as follows: tube voltage, 120 kV; tube current, 250
mA; 2-mm collimation; table speed, 2 mm/second, one rota-
tion per second; pitch, 1; and reconstruction interval, 2 mm
using a bone algorithm. The images were photographed with
a window level of –650 HU and a window width of 1800 HU.
In the final analysis, patients undergoing an operation
smaller than a lobectomy or an incomplete nodal dissection,
or patients who were revealed to have diseases other than
NSCLC by postsurgical pathologic examinations, were ex-
cluded. The stage of all patients was pathologically defined
according to the revised international staging system.9
Statistical Analysis
Statistical difference in rates of nodal metastasis among
subgroups divided by each clinical factor was analyzed by
means of the 2 test. A multivariate analysis for factors
affecting the incidence of nodal metastasis was analyzed by
means of a logistic regression model.
RESULTS
Profile of Analyzed Patients
During this period, 169 patients were registered from
12 institutes (see Appendix). Of them, 14 were eliminated
because of incomplete information. Of the 155 remaining
patients, 140 had NSCLC, three had small cell lung cancer,
and 12 had inflammatory lesions (organizing pneumonia and
tuberculoma). Of the 140 patients with NSCLC, 130 under-
went a standard lobectomy or bilobectomy with a systemic
mediastinal nodal dissection and 10 underwent a lesser re-
section or an omission of mediastinal node dissection by the
surgeon’s decision. Of them, 114 patients with adenocarci-
TABLE 1. Profile of All Patients*
Stage Pathologic Stage No. (%)
IA T1N0M0 88 (77.2)
IB T2N0M0 10 (8.8)
IIA T1N1M0 8 (7.0)
IIIA T1N2M0 7 (6.1)
IIIB T4N0M0 1 (0.9)
*There were 56 male patients and 58 female patients, with a mean age of 64.7 yr
(range, 40–85 yr).
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noma were subjected to the analysis. The profiles of the 114
patients are summarized in Table 1. The mean age was 64.7
years, ranging from 40 to 85 years (there were 56 male
patients and 58 female patients). The pathologic lymph node
metastasis was recognized in 15 patients (13.2%). Pathologic
stages were T1N0M0 in 88 patients (77.2%), T2N0M0 in
eight (7.0%), T1N1M0 in eight (7.0%), T1N2M0 in seven
(6.1%), and T4N0M0 in one (0.9%). The detailed information
for the 26 up-staged patients (22.8%) is summarized in Table
2. The reasons for T2 in a total of 10 patients were pleural
invasion in five and a diameter of more than 3 cm in five. The
reason for T4 in one patient was intrapulmonary metastasis.
The location of the nodal metastases was the intrapulmonary
node in four patients, the hilar node in four, and the medias-
tinal node in seven. Of the seven patients with mediastinal
node metastasis, three had single and skip metastases from
the upper lobes.
Clinicopathologic Analysis for Lymph Node
Metastasis in Adenocarcinoma Patients
The relationship between the incidence of nodal metas-
tasis and the radiographic features in HR-CT in adenocarci-
nomas was examined (Table 3). Of these factors, only the
elevated serum CEA was significantly associated with lymph
node metastasis. In 17 patients with elevated CEA, seven
(41.2%) had nodal metastasis, whereas only eight of 97
patients (8.2%) with normal CEA had nodal metastasis (p 
0.0012). The presence of intratumoral air-bronchogram
tended to predict nodal metastasis. In 78 patients with pres-
ence of air-bronchogram, seven (9.0%) had nodal metastasis,
whereas eight of 36 patients (22.2%) with absence of air-
bronchogram had nodal metastasis (p  0.0601). Although
no statistical significance was observed, only one of 21
patients (4.8%) with absence of retraction sign had nodal
metastasis. The negative-predictive value for lymph node
metastasis was 91.8% in normal serum CEA, 95.1% in the
absence of retraction sign, and 91.0% in the presence of
air-bronchogram. The tumor size and the GGA ratio and
notching were not associated with the incidence of nodal
metastasis.
A logistic multivariate analysis revealed elevated serum
CEA, presence of retraction sign, and absence of intratumoral
air-bronchogram to be independent factors for predicting
nodal metastasis, with hazard ratios of 12.44 ((p  0.0003),
6.53 (p 0.0533), and 0.17 ((p 0.0073), respectively (Table 4).
When the relationship between each size of the tumor
and a lymph node dissection was analyzed, lymph node
metastasis was not observed in adenocarcinoma cases with
tumors measuring 10 mm or less in diameter (Table 5). In a
detailed analysis of the relationship between the GGA ratio
and the incidence of lymph node metastasis, lymph node
metastasis was observed in each grade of the GGA ratio
TABLE 3. Analysis of the Clinicopathologic Factors for Lymph Node Metastasis in Lung
Adenocarcinoma
No. of Patients N0 N1/2 N1–2 (%) p Value NPV (%)
Gender 0.4467
Male 56 50 4/5 15.5
Female 58 49 4/2 10.7
Smoking 0.5948
Yes 46 39 3/4 15.2
No 68 60 5/3 11.8
CEA 0.0012
Elevated 17 10 3/4 41.2 58.8
Normal 97 89 5/3 8.2 91.8
Size 0.8955
20 mm 59 51 5/3 13.6
20 mm 55 48 3/4 12.7
GGA ratio 0.7817
0.5 57 49 5/3 14.0
0.5 57 50 3/4 12.3
Retraction sign 0.1636
Presence 93 79 8/6 15.0 84.9
Absence 21 20 0/1 4.8 95.2
Air-bronchogram 0.0601
Presence 78 71 4/3 9.0 91.0
Absence 36 28 4/4 22.2 77.8
Notching 0.5167
Presence 30 25 3/2 16.7
Absence 84 74 5/5 11.9
NPV, negative predictive value for node metastasis.
I. Yoshino et al. Journal of Thoracic Oncology • Volume 1, Number 8, October 2006
Copyright © 2006 by the International Association for the Study of Lung Cancer828
(Table 6). Even in seven cases with tumors demonstrating
pure GGA, one showed lymph node metastasis.
Next, the subgroups categorized by the factors of serum
CEA level and HR-CT features such as intratumoral air-
bronchogram or retraction sign were compared for the inci-
dence of node metastasis (Table 7). None of the patients with
both features of normal serum CEA and absence of retraction
sign had node metastasis, and the difference in the rates of
node metastasis among the subgroups divided by serum CEA
(normal or elevated) and retraction sign (presence or absence)
was significant (p  0.0015). The combination of normal
serum CEA and absence of retraction sign might predict truly
negative for node metastasis in clinical stage IA NSCLC
(negative predictive value, 100%). The rate of nodal metas-
tasis in patients with a normal serum CEA and presence of
air-bronchogram (24.5%) was significantly higher than that
of the other cases (4.6%) (p  0.0001), and the negative
predictive value of this categorization for node metastasis
was 95.4%.
DISCUSSION
It is well known that the size of the primary tumor
significantly correlates with lymphatic permeation.10 Several
clinicopathologic studies by thoracic surgeons5–7,11 have re-
vealed that tumor size is associated with the incidence of
nodal metastasis in resected NSCLC, and that a lesser resec-
tion for small-sized NSCLC was proposed. In a series of 89
cases that were scheduled to undergo a segmentectomy for
clinical stage IA (20 mm) NSCLC,11 however, 12 cases
were converted to other procedures because of nodal involve-
ment and seven were converted because of intralobar inva-
sion or tumor location, and one of 70 who underwent a
segmentectomy was revealed to have intralobar nodal metas-
tasis in a postoperative pathologic examination. Therefore,
the size of the tumor was found to be a predictive factor for
the nodal status in squamous cell carcinoma but not in
adenocarcinoma of the lung. In our prospective series, one of
11 squamous cell carcinomas measuring 20 mm or less and
eight of 59 adenocarcinomas measuring 20 mm or less
showed nodal metastasis. Six (5.2%) adenocarcinomas mea-
suring less than 10 mm in diameter showed no lymph node
metastasis, and these findings correlate with a previous ret-
rospective study performed at our institute.12 In cases with
TABLE 4. Multivariate Analysis of the Clinical Predictive
Factors for Lymph Node Metastasis in Lung Adenocarcinoma
2 Value Hazard Ratio p Value
Serum CEA
Elevated/normal
12.92 12.44 0.0003
Retraction
Presence/absence
3.74 6.53 0.0533
Air-bronchogram
Presence/absence
7.19 0.17 0.0073
TABLE 5. Tumor Size and Incidence of Lymph Node
Metastasis in Lung Adenocarcinoma
Incidence of Lymph Node Metastasis (%)
Tumor Size (mm) All Cases Adenocarcinoma
10 0/6* (0.0) 0/6 (0.0)
11 to 20 10/65 (15.4) 8/53 (15.1)
20 to 30 8/53 (15.1) 7/50 (14.0)
30 0/6 (0.0) 0/5 (0.0)
*One of the six cases showed a positive serum CEA level.
TABLE 6. GGA Ratio and the Incidence of Lymph Node
Metastasis in Lung Adenocarcinoma
GGA Ratio Incidence of Lymph Node Metastasis (%)
0–0.25 6/36 (16.7)
0.25–0.5 1/21 (4.8)
0.5–0.75 2/15 (13.3)
0.75–1.0 5/35 (14.3)
1.0 1/7 (7.1)
TABLE 7. Analysis of the Serum CEA and Radiologic Features as Predictive
Clinicopathologic Factors of Node-Negative Adenocarcinoma
Factors No. of Patients N0 N1/2 N1-2(%) NPV(%) p Value
CEA/retraction 0.0015
Normal/absence 18 18 0/0 0.0 100*
Normal/presence 79 71 5/3 10.1 89.9
Elevated/absence 4 2 1/1 50.0 50.0
Elevated/presence 13 8 2/3 38.5 61.5
CEA/air-bronchogram 0.0001
Normal/presence 65 62 2/1 4.6 95.4†
Normal/absence 32 27 3/2 15.6 74.6
Elevated/presence 13 9 2/2 30.8 69.2
Elevated/absence 4 1 1/2 75.0 25.0
*Calculated as 18/(18  0).
†Calculated as 62/(62  3).
NPV, negative predictive value.
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tumors larger than 1 cm, however, tumor size did not corre-
late with the incidence of nodal metastasis. In this study, two
of the node-positive cases exhibited tumor sizes of 12 mm
and 13 mm, and both were positive for serum CEA. Based on
the uncertainty regarding the clinical measurement of the
tumor diameter, errors ranging from 1 to 3 mm are considered
to be unavoidable. Therefore, the size criteria may be inap-
propriate for clinically predicting nodal metastasis.
Noguchi et al.13 classified six subgroups of small-sized
adenocarcinomas according to their pathologic features. Lo-
calized bronchioloalveolar carcinoma (BAC) without any
invasive growth, referred to as Noguchi type A or B, showed
no nodal metastasis and no relapse following curative sur-
gery. The Noguchi types A and B adenocarcinoma might be
“early lung cancer”; however, such types can hardly be
distinguished preoperatively. In recent retrospective studies,
the presence of GGA in tumors on HR-CT could help identify
node-negative adenocarcinomas because intratumoral GGA
is a reflection of a lining growth pattern under alveolar septa,
which is a feature of Noguchi types A and B. Matsuguma et
al.14 advocated that adenocarcinomas measuring 20 mm or
less in size were negative for lymph node metastasis when the
diameter of the GGA region occupied 50% or more of the
total diameter of the tumor. In this study, we also investigated
whether the proportion of the GGA region in the tumors was
associated with nodal metastasis or not; however, no corre-
lation was observed. Recently, a pathologic classification of
lung adenocarcinoma in special reference to a component of
BAC and to invasiveness has been proposed.15 Most likely,
the amount of the GGA portion is not positively related to
invasiveness.
In this study, the presence of air-bronchogram and
retraction sign was effective for predicting nodal metastasis
in adenocarcinomas. The presence of an air-bronchogram
may reflect the preserved alveolar and bronchiole space in the
tumor proliferating in the lining pattern. Such a growth
pattern is a feature of BAC. In contrast, the retraction of the
neighboring structure by pulmonary adenocarcinoma is con-
sidered to result from collapse of involving parenchyma and
intratumoral scar formation. Scar-like fibrosis in the central
portion is a feature of invasive lung adenocarcinoma,16 which
is categorized as type C according to the Noguchi classifica-
tion13 or as “adenocarcinoma with invasiveness” according to
the classification of the Memorial Sloan-Kettering Cancer
Center.15 The radiographic features of the presence of an
intratumoral air-bronchogram and the absence of pleural
retraction have recently been reported to be significantly
associated with the prognosis of lung adenocarcinoma17,18;
therefore, those radiologic features were included in this
study as clinical factors to be investigated.
A significant association between serum CEA and
nodal metastasis was recognized in this prospective study.
Several authors have reported that an elevated serum CEA
level suggested spread of the disease to the regional lymph
nodes or to distant organs in cancer even if conventional
clinical staging indicated them to be resectable.19,20 In our
present data, 41% of the elevated CEA cases showed nodal
metastasis; therefore, special caution may be required at
surgery for cases with elevated CEA even if no apparent
nodal swelling is observed on preoperative CT scans. How-
ever, 8.2% of the cases with normal CEA levels had nodal
metastasis. To select node-negative adenocarcinomas, the
combination of serum CEA and radiographic features was
thus found to be significantly effective. Even in a limited
number of cases, all 18 adenocarcinoma cases with normal
CEA levels and absence of retraction sign exhibited no lymph
node metastasis in adenocarcinoma even though they consti-
tuted 15.5% of all adenocarcinomas (n  114) and 18% of the
node-negative clinical stage IA adenocarcinomas (n  99).
CONCLUSIONS
The combination of serum CEA level and HR-CT
features may therefore be useful for predicting the presence
of node-negative lung adenocarcinoma, although the sensi-
tivity of this diagnostic modality is still low. The present
information might help to decide whether limited resection,
stereotactic radiotherapy,21 or radiofrequency ablation ther-
apy is indicated22 for peripheral small-sized lung adenocar-
cinomas.
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The principal investigators of institutions that partici-
pated in this study included the following: K. Yamazaki, T.
Tagawa, T. Kameyama, and T. Yohena (Kyushu University
Hospital); R. Maruyama, T. Okamoto, and R. Suemitsu
(National Kyushu Cancer Center, Fukuoka, Japan); M.
Takenoyama (Kitakyushu Municipal Medial Center, Kitaky-
ushu, Japan); T. Kometani (National Kyushu Medical Center,
Fukuoka, Japan); K. Sakada, M. Tomiyasu, and A. Osoegawa
(National Fukuoka Hospital, Fukuoka, Japan); C. Ushijima
(National Beppu Medical Center, Beppu, Japan); F. Shoji
(Saga Prefectural Hospital Koseikan, Saga, Japan); M.
Hamatake (Fukuoka Municipal Hospital, Fukuoka, Japan); K.
Ondo and S. Fukuyama (Matsuyama Red Cross Hospital,
Matsuyama, Japan); Y. Fukuyama (Nakatsu Municipal Hos-
pital, Nakatsu, Japan); M. Yamaguchi (National Fukuoka
Higashi Medical Center, Koga, Japan); and S. Tsukamoto
(Hiroshima Red Cross Hospital, Hiroshima, Japan).
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